– Interview with William Balch, Ph.D., and Evan Powers, Ph.D., from The Scripps Research Institute.

Previous articleInhibitex Obtains License to HCV Polymerase Inhibitors
Next articleInviragen Granted $600,000 to Develop Flu Vaccines